Clinical protocol. A phase II study: efficacy of the gene therapy of the MVA E2 recombinant virus in the treatment of precancerous lesions (NIC I and NIC II) associated with infection of oncogenic human papillomavirus.
Corona Gutierrez
Carlos Manual
CM
Hospital General del Zona 2-A, Instituto Mexicano del Seguro Social, Francisco del Paso y Troncoso, Mexico City, Mexico.
Tinoco
Alberto
A
López Contreras
Mario
M
Navarro
Tania
T
Calzado
Patricia
P
Vargas
Laura
L
Reyes
Lise
L
Posternak
Roberto
R
Rosales
Ricardo
R
D002985:Clinical Protocols; D015316:Genetic Therapy; D006801:Humans; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000628:therapy*; D011230:Precancerous Conditions / Q000628:therapy*; D014412:Tumor Virus Infections / Q000628:therapy*; D014616:Vaccinia virus / Q000235:genetics